Afuco™ Anti-Human SHH ADCC Therapeutic Antibody (MEDI-5304), ADCC Enhanced
Anti-SHH ADCC Enhanced Antibody (MEDI-5304) is an ADCC enhanced antibody produced by our Afuco™ platform. MEDI-5304 is the first fully human hedgehog antibody which inhibited transcription of hedgehog target genes and osteoblast differentiation of C3H10T1/2 cells. MEDI-5304 represents a potent dual hedgehog inhibitor suitable for continued development to evaluate efficacy and safety in human patients with tumors harboring elevated levels of SHH or IHH.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-544CL |
| Pricing | Inquiry |
| Host | Human |
| Target | SHH |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |